City
Epaper

WHO issues Emergency Use Validation for Pfizer, BioNTech COVID-19 vaccine

By ANI | Updated: January 1, 2021 03:40 IST

The World Health Organization said on Thursday it had issued an emergency use validation for the vaccine against the coronavirus developed by the Pfizer and BioNTech companies, the first one since the start of the pandemic.

Open in App

The World Health Orgzation said on Thursday it had issued an emergency use validation for the vaccine against the coronavirus developed by the Pfizer and BioNTech compes, the first one since the start of the pandemic.

"The World Health Orgzation (WHO) today listed the Comirnaty COVID-19 mRNA vaccine for emergency use, making the Pfizer/BioNTech vaccine the first to receive emergency validation from WHO since the outbreak began a year ago," the WHO said in a statement.

The WHO decision has enabled UNICEF and the Pan-American Health Orgzation to procure the vaccine for distribution to the countries in need.

"WHO and our partners are working night and day to evaluate other vaccines that have reached safety and efficacy standards. We encourage even more developers to come forward for review and assessment. It's vitally important that we secure the critical supply needed to serve all countries around the world and stem the pandemic," WHO Assistant-Director General for Access to Medicines and Health Products Mariangela Simao said.

The WHO declared the COVID-19 outbreak a pandemic on March 11. To date, more than 83.1 million people have been infected with the coronavirus worldwide, with over 1.81 million fatalities, according to Johns Hopkins University. (/Sputnik)

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

MumbaiMumbai: ₹30 Lakh Bank Fraud Unearthed at Mumbai District Central Co-operative Bank

TechnologyStrong science, effective delivery, people’s participation driving India’s public health: JP Nadda

HealthStrong science, effective delivery, people’s participation driving India’s public health: JP Nadda

BusinessTN sanctions Rs 289.63 crore relief for crop losses caused by unseasonal rains

NationalStrong science, effective delivery, people’s participation driving India’s public health: JP Nadda

International Realted Stories

InternationalPakistan: Human rights body highlights 'suffocating impact' of restricting press freedom

InternationalBNP's Tarique Rahman set to return to Bangladesh after 17 years on Thursday

InternationalIndia urges dialogue amid damage reports of Hindu deity idol in Thai-Cambodia clashes

InternationalBangladesh: Tarique Rahman’s address likely to spell political, diplomatic agenda

InternationalDisrespectful act: MEA on demolition of Hindu deity statue during Thai-Cambodia border clashes